inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on February 24
inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on February 24
SOMERSET, N.J., Feb. 5, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. today announced that it will release its Fourth Quarter and Full Year 2009 results and conduct a conference call on Wednesday, February 24 at 8:30 a.m. EST.
To listen, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). The conference call will also be webcast live on the Internet at www.inventivhealth.com/about_us/n_webcasts.aspx. To listen, please go to the site at least 15 minutes in advance of the call to register, download and install any necessary audio software.
An archived audio webcast of the presentation can be accessed by logging on to http://www.inventivhealth.com/about_us/n_webcasts.aspx and a replay of the call will be available immediately following the call through March 3, 2010 at 800-642-1687. The conference ID number for the replay is 55221445.
About inVentiv Health
inVentiv Health, Inc. is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
CONTACT: inVentiv Health, Inc.
Investors/Corporate:
David Bassin, CFO
(732) 537-4804
investor@inventivhealth.com
Media:
Marcia Frederick
(614) 543-6281
mfrederick@inventivhealth.com
